EU OK for New Drugs for Lung Cancer and Follicular Lymphoma

Capmatinib for lung cancer and mosunetuzumab for follicular lymphoma have been recommended for approval in the European Union.
International Approvals

source https://www.medscape.com/viewarticle/972650?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost